Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romiplostim vs placebo in adult persistent or chronic primary ITP
CTR20150395Phase 3Completed
- Sponsor
- Kyowa Kirin
- Start
- Aug 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of romiplostim in chronic primary immune thrombocytopenia (ITP), sponsored by Kyowa Kirin. Started Aug 2015; status: completed.
02
Drugs
romiplostim
03
Conditions
chronic primary immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on CTR20150395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150395.